Nutralife Biosciences Stock Analysis
| NLBS Stock | USD 0.0001 0.00 0.00% |
Nutralife Biosciences is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Nutralife Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Nutralife Biosciences is worth, separate from its market price. There are two main types of Nutralife Biosciences' stock analysis: fundamental analysis and technical analysis.
The Nutralife Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Nutralife |
Nutralife Pink Sheet Analysis Notes
About 46.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Nutralife Biosciences had not issued any dividends in recent years. NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.The quote for Nutralife Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nutralife Biosciences contact Edgar Ward at 888 509 8901 or learn more at https://www.nutralifebiosciences.com.Nutralife Biosciences Investment Alerts
| Nutralife Biosciences generated a negative expected return over the last 90 days | |
| Nutralife Biosciences has some characteristics of a very speculative penny stock | |
| Nutralife Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Nutralife Biosciences currently holds 10 K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K. | |
| Nutralife Biosciences currently holds about 51.8 K in cash with (487.39 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Nutralife Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nutralife Biosciences's market, we take the total number of its shares issued and multiply it by Nutralife Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nutralife Biosciences, as well as the relationship between them.Nutralife Biosciences Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nutralife Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nutralife Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nutralife Biosciences Outstanding Bonds
Nutralife Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nutralife Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nutralife bonds can be classified according to their maturity, which is the date when Nutralife Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| OCPMR 5125 23 JUN 51 Corp BondUS67091TAE55 | View | |
| OCPMR 45 22 OCT 25 Corp BondUS67091TAC99 | View | |
| OCPMR 375 23 JUN 31 Corp BondUS67091TAD72 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View |
About Nutralife Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nutralife Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nutralife shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nutralife Biosciences. By using and applying Nutralife Pink Sheet analysis, traders can create a robust methodology for identifying Nutralife entry and exit points for their positions.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Nutralife Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.